Azithromycin Powder, For Suspension
Product Images NDC 59651-007

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Azithromycin (NDC 59651-007). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (100 mg per 5 mL (15 mL Bottle))

Package Label-principal Display Panel (100 mg per 5 mL (15 mL Bottle))
This is a prescription drug, Azithromycin, in oral suspension form with a concentration of 100mg per 5ml. It comes in a dry powder form with cherry and ripe banana flavors. Once constituted, each teaspoonful contains 100 mg Azithromycin. This drug is suitable for oral use only, and must be shaken well before use. The usual dosage, side effects, and other prescribing information are available on the accompanying document. Store dry powder at 20° to 25°C (68°-77°F). When mixing, a bottle of water should be added to the powder and stored between 5° to 30°C (41 to 86°F) and shaken well. The suspension should be used within 10 days of the preparation period. The drug comes from Aurobindo Pharma USA and is made in India.*
FDA Label Image

Package Label-principal Display Panel (100 mg per 5 mL (15 mL Carton Label))

Package Label-principal Display Panel (100 mg per 5 mL (15 mL Carton Label))
Azithromycin for Oral Suspension USP is a cherry and ripe banana-flavored medication used for oral use only. Its bottle should be shaken well before using. Each teaspoonful (5 mL) contains azithromycin dihydrate USP equivalent to 100 mg of azithromycin. The directions for storage after mixing should be followed properly. To use, add 9L of water, shake well, and use within 10 days. Store dry powder at 20° to 25°C (68° to 77°F). The product is Rx only and distributed by Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (200 mg per 5 mL (30 mL Bottle))

Package Label-principal Display Panel (200 mg per 5 mL (30 mL Bottle))
This is a description of Azithromycin, an oral suspension medication used only through prescription for the treatment of bacterial infections. The medication comes in the form of a powder, which when mixed with water, becomes a cherry and ripe banana-flavored liquid suspension. The medication contains 200mg of Azithromycin USP in every 5ml tablespoonful. The usual dosage must be determined by a physician. The dry powder should be stored at temperatures ranging from 20°C to 25°C in a controlled environment, and must be protected from freezing. When being prepared for use, the medication must be shaken well and used within 10 days. Aurobindo Pharma USA, Inc. distributes the medication and it is made in India.*
FDA Label Image

Package Label-principal Display Panel (200 mg per 5 mL (30 mL Carton Label))

Package Label-principal Display Panel (200 mg per 5 mL (30 mL Carton Label))
Azithromycin for Oral Suspension is a drug prescribed for oral use only. The solution comes in a flavored cherry and ripe banana flavor for ease of use. It has an NDC number of 59651-008-30 with 200 mg per 5 mL of azithromycin dihydrate USP. Each teaspoonful contains 200mg of azithromycin. The usual dosage and mixing directions are found in the accompanying prescribing information. The dry powder needs to be stored in a controlled USP room temperature of 20° to 25°C. It is manufactured by Aurobindo Pharma USA, Inc. and has a code of TS/DRUGS/19/1998. Shake well before use, store suspension at 5° to 30°C (41° to 86°F), protect from freezing, and use within 10 days of mixing.*
FDA Label Image

Chemical Structure (Azithromycin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.